NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

More BS from a confounding opinion that provides misleading information.
However, the fact that the data has been reviewed and analyzed by doctors, scientist and professionals who all out weight the confounded opinion. All SEC information was submitted prior to release of the TLD data presentation on 5/10/22. In other words, NWBO's SEC information was released back in 2021 as risks. Again, the risk factors were addressed prior to the data results. It appears that shorts continue to spread bogus information. As a scientist, I agree with my fellow colleagues and support the fact that NWBO's data results are both noteworthy and impressive. This supersedes all confounded opinions attempting mislead people. The good news is that there are a significant number of people who also agree that NWBO will prevail.